The distribution of the haplotypes did not differ between all the breast cancer cases and controls (p = 0.45, p = 0.49 and p = 0.55 for RAD51, XRCC3, and XRCC2, respectively) nor between the familial cases and controls (p = 0.66, p = 0.14 and p = 0.80 for RAD51, XRCC3, and XRCC2, respectively). This evidence concerns the gene XRCC2 and breast carcinoma.